An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10

被引:144
作者
Nelson, Josh D.
Brunel, Florence M.
Jensen, Richard
Crooks, Emma T.
Cardoso, Rosa M. F.
Wang, Meng
Hessell, Ann
Wilson, Ian A.
Binley, James M.
Dawson, Philip E.
Burton, Dennis R.
Zwick, Michael B.
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[6] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
关键词
D O I
10.1128/JVI.02588-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal external region (MPER) of human immunodeficiency virus type I (HIV-1) gp41 bears the epitopes of two broadly neutralizing antibodies (Abs), 2F5 and 4E10, making it a target for vaccine design. A third Ab, Fab Z13, had previously been mapped to an epitope that overlaps those of 2F5 and 4E10 but only weakly neutralizes a limited set of primary isolates. Here, libraries of Fab Z13 variants displayed on phage were engineered and affinity selected against an MPER peptide and recombinant gp41. A high-affinity variant, designated Z13e1, was isolated and found to be similar to 100-fold improved over the parental Fab not only in binding affinity for the MPER antigens but also in neutralization potency against sensitive HIV-1. Alanine scanning of MPER residues 664 to 680 revealed that N671 and D674 are crucial for peptide recognition as well as for the neutralization of HIV-1 by Z13e1. Ab competition studies and truncation of MPER peptides indicate that Z13e1 binds with high affinity to an epitope between and overlapping with those of 2F5 and 4E10, with the minimal peptide epitope WASLWNWFDITN. Still, Z13e1 remained about an order of magnitude less potent than 4E10 against several isolates of pseudotyped HIV-1. The sum of our molecular analyses with Z13e1 suggests that the segment on the MPER of gp41 between the 2F5 and 4E10 epitopes is exposed on the functional envelope trimer but that access to the specific Z13e1 epitope within this segment is limited. Thus, the ability of MPER-bearing immunogens to elicit potent HIV-1-neutralizing Abs may depend in part on recapitulating the particular constraints that the functional envelope trimer imposes on the segment of the MPER to which Z13e1 binds.
引用
收藏
页码:4033 / 4043
页数:11
相关论文
共 64 条
  • [21] Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
    Haynes, BF
    Fleming, J
    St Clair, EW
    Katinger, H
    Stiegler, G
    Kunert, R
    Robinson, J
    Scearce, RM
    Plonk, K
    Staats, HF
    Ortel, TL
    Liao, HX
    Alam, SM
    [J]. SCIENCE, 2005, 308 (5730) : 1906 - 1908
  • [22] ENGINEERING HYBRID GENES WITHOUT THE USE OF RESTRICTION ENZYMES - GENE-SPLICING BY OVERLAP EXTENSION
    HORTON, RM
    HUNT, HD
    HO, SN
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 61 - 68
  • [23] A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein
    Jiang, S
    Lin, K
    Lu, M
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 10213 - 10217
  • [24] Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates
    Kessler, JA
    McKenna, PM
    Emini, EA
    Chan, CP
    Patel, MD
    Gupta, SK
    Mark, GE
    Barbas, CF
    Burton, DR
    Conley, AJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (07) : 575 - 582
  • [25] The need for a global HIV vaccine enterprise
    Klausner, RD
    Fauci, AS
    Corey, L
    Nabel, GJ
    Gayle, H
    Berkley, S
    Haynes, BF
    Baltimore, D
    Collins, C
    Douglas, RG
    Esparza, J
    Francis, DP
    Ganguly, NK
    Gerberding, JL
    Johnston, MI
    Kazatchkine, MD
    McMichael, AJ
    Makgoba, MW
    Pantaleo, G
    Piot, P
    Shao, YM
    Tramont, E
    Varmus, H
    Wasserheit, JN
    [J]. SCIENCE, 2003, 300 (5628) : 2036 - 2039
  • [26] Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement
    Kostrikis, LG
    Cao, YZ
    Ngai, H
    Moore, JP
    Ho, DD
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 445 - 458
  • [27] Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
    Labrijn, AF
    Poignard, P
    Raja, A
    Zwick, MB
    Delgado, K
    Franti, M
    Binley, J
    Vivona, V
    Grundner, C
    Huang, CC
    Venturi, M
    Petropoulos, CJ
    Wrin, T
    Dimitrov, DS
    Robinson, J
    Kwong, PD
    Wyatt, RT
    Sodroski, J
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (19) : 10557 - 10565
  • [28] Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein
    Liang, XP
    Munshi, S
    Shendure, J
    Mark, G
    Davies, ME
    Freed, DC
    Montefiori, DC
    Shiver, JW
    [J]. VACCINE, 1999, 17 (22) : 2862 - 2872
  • [29] Defining the protective antibody response for HIV-1
    Mascola, JR
    [J]. CURRENT MOLECULAR MEDICINE, 2003, 3 (03) : 209 - 216
  • [30] Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
    Moore, JP
    Cao, YZ
    Leu, J
    Qin, LM
    Korber, B
    Ho, DD
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 427 - 444